Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Tarighatnia A"'
Publikováno v:
Frontiers in Biomedical Technologies, Vol 11, Iss 1 (2024)
Hybrid nanoparticles have emerged as promising tools in cancer diagnosis and treatment, offering the potential for early detection and precise eradication of malignant cells by integrating diverse materials. However, navigating the intricacies, limit
Externí odkaz:
https://doaj.org/article/c7af389b90cc4c228d3e3fdb958bb366
Publikováno v:
In Journal of Drug Delivery Science and Technology October 2023 88
Autor:
Kheyrolahzadeh, Keyvan, Tohidkia, Mohammad Reza, Tarighatnia, Ali, Shahabi, Parviz, Nader, Nader D., Aghanejad, Ayuob
Publikováno v:
In Life Sciences 1 September 2023 328
Autor:
Amraee, A. ∗, †, Tohidkia, M.R. ∗, Darvish, L. ‡, Tarighatnia, A. §, Robatmili, N. ||, ¶, Rahimi, A. ¶, Rezaei, N. ¶, Ansari, F. ∗∗, ††, Teshnizi, S.H. ††, Aghanejad, A. ∗
Publikováno v:
In Clinical Oncology September 2023 35(9):576-585
Autor:
Reza Gerami, Mana Altafi Altafi, Zahra Shahpar, Ensieh Izadpanah, Siamak Soltani, Omid Naderloo, Ali Tarighatnia
Publikováno v:
Frontiers in Biomedical Technologies, Vol 11, Iss 4 (2023)
Breast Cancer (BC) is the leading cause of cancer-related deaths in women and the most common cancer worldwide. It is classified based on its anatomical origin, the presence of Human Epidermal Growth Factor Receptor 2 (HER-2), and the presence of Est
Externí odkaz:
https://doaj.org/article/0b2f61e77e394d01b3e6c6d7d8d08755
Publikováno v:
Frontiers in Biomedical Technologies, Vol 10, Iss 3 (2023)
No Abstract.
Externí odkaz:
https://doaj.org/article/641bfb3928d2479aaf7883c3bde9ef4d
Publikováno v:
In Life Sciences 15 October 2022 307
Autor:
Jiang, Shide, Zhang, Yusong, Alsaikhan, Fahad, Turki Jalil, Abduladheem, Khanbabayi Gol, Mehdi, Tarighatnia, Ali
Publikováno v:
In Journal of Drug Delivery Science and Technology October 2022 76
Autor:
Nasim Jamshidi, Ali Tarighatnia, Mona Fazel Ghaziyani, Fakhrossadat Sajadian, Maryam Olad ghaffari, Nader D Nader
Publikováno v:
Frontiers in Biomedical Technologies, Vol 11, Iss 1 (2023)
Purpose: We synthesized folic acid-conjugated Fe3O4/Au-pralidoxime chloride Nanoparticles (Fe2O3/Au@PAM NPs) for use as dual-modal contrast agents for Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) in the diagnosis of breast cancer.
Externí odkaz:
https://doaj.org/article/93fc5db673294660b079dc914228f24e
Autor:
Kadkhoda, Jamileh, Tarighatnia, Ali, Tohidkia, Mohammad Reza, Nader, Nader D., Aghanejad, Ayuob
Publikováno v:
In Life Sciences 1 June 2022 298